Empowered Funds
ARMP icon

Empowered Funds’s Armata Pharmaceuticals ARMP Stock Holding History

Empowered Funds’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$149K Buy
+40,688
New +$194K ﹤0.01% 2347

Other funds holding ARMP

Madison Asset Management
Madison Asset Management Madison, Wisconsin $8.05B AUM 13.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $493M AUM 21.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $6.26B AUM 6.09% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Empowered Funds's ARMP Position: Q3 2026 in Review

Empowered Funds opened a new position in Armata Pharmaceuticals (ARMP) in Q3 2026: 40,688 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #2347 among its holdings.

47 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.

  • Empowered Funds held 40,688 shares of Armata Pharmaceuticals worth $149K as of Q3 2026.
  • Armata Pharmaceuticals was a new Empowered Funds position in Q3 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2347 holding.
  • 47 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.